These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16541356)

  • 1. Toxicity and efficacy of isolated lung perfusion with gemcitabine in a rat model of pulmonary metastases.
    Van Putte BP; Hendriks JM; Romijn S; De Greef K; Van Schil PE
    Thorac Cardiovasc Surg; 2006 Mar; 54(2):129-33. PubMed ID: 16541356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated lung perfusion with gemcitabine in a rat: pharmacokinetics and survival.
    Van Putte BP; Hendriks JM; Romijn S; Pauwels B; Friedel G; Guetens G; De Bruijn EA; Van Schil PE
    J Surg Res; 2003 Feb; 109(2):118-22. PubMed ID: 12643852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics after pulmonary artery perfusion with gemcitabine.
    Van Putte BP; Hendriks JM; Romijn S; Pauwels B; De Boeck G; Guetens G; De Bruijn E; Van Schil PE
    Ann Thorac Surg; 2003 Oct; 76(4):1036-40; discussion 1040. PubMed ID: 14529980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy with gemcitabine with isolated lung perfusion for the treatment of pulmonary metastases.
    Van Putte BP; Hendriks JM; Romijn S; Pauwels B; Vermorken JB; Van Schil PE
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):125-30. PubMed ID: 15999051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified approach of administering cytostatics to the lung: more efficient isolated lung perfusion.
    van Putte BP; Hendriks JM; Guetens G; de Boeck G; de Bruijn EA; van Schil PE; Folkerts G
    Ann Thorac Surg; 2006 Sep; 82(3):1033-7. PubMed ID: 16928530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective pulmonary artery perfusion with melphalan is equal to isolated lung perfusion but superior to intravenous melphalan for the treatment of sarcoma lung metastases in a rodent model.
    Den Hengst WA; Hendriks JM; Van Hoof T; Heytens K; Guetens G; de Boeck G; Lardon F; Van Schil PE
    Eur J Cardiothorac Surg; 2012 Aug; 42(2):341-7; discussion 347. PubMed ID: 22345285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated lung perfusion with melphalan prolongs survival in a rat model of metastatic pulmonary adenocarcinoma.
    Hendriks JM; Van Schil PE; Van Oosterom AA; Kuppen PJ; Van Marck E; Eyskens E
    Eur Surg Res; 1999; 31(3):267-71. PubMed ID: 10352355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated lung perfusion with gemcitabine combined with radiotherapy: no additional lung toxicity in an experimental model.
    Van Thielen J; Wittock A; Hendriks J; den Hengst W; De Pooter C; Van den Weyngaert D; Pauwels P; Van Schil P
    Eur J Cardiothorac Surg; 2012 Oct; 42(4):712-8. PubMed ID: 22345281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and delayed toxicity of gemcitabine administered during isolated lung perfusion: a preclinical dose-escalation study in pigs.
    Pagès PB; Derangere V; Bouchot O; Magnin G; Charon-Barra C; Lokiec F; Ghiringhelli F; Bernard A
    Eur J Cardiothorac Surg; 2015 Aug; 48(2):228-35. PubMed ID: 25414426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases.
    Koshkina NV; Kleinerman ES
    Int J Cancer; 2005 Sep; 116(3):458-63. PubMed ID: 15800950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-pass isolated lung perfusion versus recirculating isolated lung perfusion with melphalan in a rat model.
    Van Putte BP; Hendriks JM; Romijn S; Guetens G; De Boeck G; De Bruijn EA; Van Schil PE
    Ann Thorac Surg; 2002 Sep; 74(3):893-8; discussion 898. PubMed ID: 12238857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated lung perfusion for the treatment of pulmonary metastases an experimental study in the rat.
    Van Schil P; Hendriks J
    Verh K Acad Geneeskd Belg; 1999; 61(4):517-50. PubMed ID: 10500475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of standard-dose and low-dose gemcitabine regimens in pancreatic adenocarcinoma patients: a prospective randomized trial.
    Sakamoto H; Kitano M; Suetomi Y; Takeyama Y; Ohyanagi H; Nakai T; Yasuda C; Kudo M
    J Gastroenterol; 2006 Jan; 41(1):70-6. PubMed ID: 16501860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged gemcitabine infusion in advanced non-small cell lung carcinoma: a randomized phase II study of two different schedules in combination with cisplatin.
    Ceribelli A; Gridelli C; De Marinis F; Fabi A; Gamucci T; Cortesi E; Barduagni M; Antimi M; Maione P; Migliorino MR; Giannarelli D; Cognetti F
    Cancer; 2003 Jul; 98(2):337-43. PubMed ID: 12872354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of single-agent gemcitabine in advanced non-small cell lung cancer: a review.
    Hansen HH; Sørensen JB
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-38-S7-41. PubMed ID: 9194478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated lung perfusion with FUDR in the rat: pharmacokinetics and survival.
    Port JL; Ng B; Ellis JL; Nawata S; Lenert JT; Burt ME
    Ann Thorac Surg; 1996 Sep; 62(3):848-52. PubMed ID: 8784018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of gemcitabine toxicity with a brief course of oral corticosteroid therapy.
    Vander Els NJ; Miller V
    Chest; 1998 Dec; 114(6):1779-81. PubMed ID: 9872221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II studies of gemcitabine for non-small cell lung cancer in Japan.
    Fukuoka M; Takada M; Yokoyama A; Kurita Y; Niitani H
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-42-S7-46. PubMed ID: 9194479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine: new indication. Relapsed ovarian cancer: simply more toxic. Increases haematologic toxicity but not overall survival.
    Prescrire Int; 2009 Aug; 18(102):156. PubMed ID: 19746525
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolated lung perfusion with FUDR is an effective treatment for colorectal adenocarcinoma lung metastases in rats.
    Ng B; Lenert JT; Weksler B; Port JL; Ellis JL; Burt ME
    Ann Thorac Surg; 1995 Jan; 59(1):205-8. PubMed ID: 7818325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.